317 related articles for article (PubMed ID: 30665494)
1. Long Noncoding RNA Antisense Noncoding RNA in the INK4 Locus Correlates With Risk, Severity, Inflammation and Infliximab Efficacy in Crohn's Disease.
Ge Q; Dong Y; Lin G; Cao Y
Am J Med Sci; 2019 Feb; 357(2):134-142. PubMed ID: 30665494
[TBL] [Abstract][Full Text] [Related]
2. Long non-coding RNA antisense non-coding RNA in the INK4 locus expression correlates with increased disease risk, severity, and inflammation of allergic rhinitis.
Qian X; Shi S; Zhang G
Medicine (Baltimore); 2019 May; 98(20):e15247. PubMed ID: 31096432
[TBL] [Abstract][Full Text] [Related]
3. Long noncoding RNAs antisense noncoding RNA in the INK4 locus (ANRIL) correlates with lower acute exacerbation risk, decreased inflammatory cytokines, and mild GOLD stage in patients with chronic obstructive pulmonary disease.
Ge J; Geng S; Jiang H
J Clin Lab Anal; 2019 Feb; 33(2):e22678. PubMed ID: 30230590
[TBL] [Abstract][Full Text] [Related]
4. Circulating long noncoding RNA ANRIL downregulation correlates with increased risk, higher disease severity and elevated pro-inflammatory cytokines in patients with acute ischemic stroke.
Feng L; Guo J; Ai F
J Clin Lab Anal; 2019 Jan; 33(1):e22629. PubMed ID: 30069916
[TBL] [Abstract][Full Text] [Related]
5. Long non-coding RNA ANRIL serves as a potential marker of disease risk, inflammation, and disease activity of pediatric inflammatory bowel disease.
Xia H; Li S; He Y; Ren Q; Qin S
Clin Res Hepatol Gastroenterol; 2022 Apr; 46(4):101895. PubMed ID: 35227955
[TBL] [Abstract][Full Text] [Related]
6. Long Non-Coding RNA Signatures in the Ileum and Colon of Crohn's Disease Patients and Effect of Anti-TNF-α Treatment on Their Modulation.
Baldan-Martin M; Rubín de Célix C; Orejudo M; Ortega Moreno L; Fernández-Tomé S; Soleto I; Ramirez C; Arroyo R; Fernández P; Santander C; Moreno-Monteagudo JA; Casanova MJ; Casals F; Casabona S; Becerro I; Lozano JJ; Aransay AM; Chaparro M; Gisbert JP
Int J Mol Sci; 2023 Oct; 24(21):. PubMed ID: 37958675
[TBL] [Abstract][Full Text] [Related]
7. Circulating lncRNA IFNG-AS1 expression correlates with increased disease risk, higher disease severity and elevated inflammation in patients with coronary artery disease.
Xu Y; Shao B
J Clin Lab Anal; 2018 Sep; 32(7):e22452. PubMed ID: 29744951
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic value of circulating lncRNA ANRIL and its correlation with coronary artery disease parameters.
Hu Y; Hu J
Braz J Med Biol Res; 2019; 52(8):e8309. PubMed ID: 31411246
[TBL] [Abstract][Full Text] [Related]
9. Circulating miR-125a but not miR-125b is decreased in active disease status and negatively correlates with disease severity as well as inflammatory cytokines in patients with Crohn's disease.
Sun CM; Wu J; Zhang H; Shi G; Chen ZT
World J Gastroenterol; 2017 Nov; 23(44):7888-7898. PubMed ID: 29209130
[TBL] [Abstract][Full Text] [Related]
10. MALT1 reflects inflammatory cytokines, disease activity, and its chronological change could estimate treatment response to infliximab in Crohn's disease patients.
Dong X; Chen X; Ren Y
J Clin Lab Anal; 2022 Oct; 36(10):e24650. PubMed ID: 36036788
[TBL] [Abstract][Full Text] [Related]
11. Anti-tumour necrosis factor therapy enhances mucosal healing through down-regulation of interleukin-21 expression and T helper type 17 cell infiltration in Crohn's disease.
Liu C; Xia X; Wu W; Wu R; Tang M; Chen T; Xu F; Cong Y; Xu X; Liu Z
Clin Exp Immunol; 2013 Jul; 173(1):102-11. PubMed ID: 23607532
[TBL] [Abstract][Full Text] [Related]
12. Identification and validation of key long non-coding RNAs using co-expression network analysis in Crohn's disease.
Rui Q; Lu C; Song S; Zhang L
Ann Palliat Med; 2021 Sep; 10(9):9627-9639. PubMed ID: 34628888
[TBL] [Abstract][Full Text] [Related]
13. Long non-coding RNA zinc finger antisense 1 expression associates with increased disease risk, elevated disease severity and higher inflammatory cytokines levels in patients with lumbar disc degeneration.
Deng RY; Hong T; Li CY; Shi CL; Liu C; Jiang FY; Li J; Fan XM; Feng SB; Wang YF
Medicine (Baltimore); 2019 Dec; 98(52):e18465. PubMed ID: 31876730
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of ATP-activated P2X7 receptors in the intestinal mucosa is implicated in the pathogenesis of Crohn's disease.
Neves AR; Castelo-Branco MT; Figliuolo VR; Bernardazzi C; Buongusto F; Yoshimoto A; Nanini HF; Coutinho CM; Carneiro AJ; Coutinho-Silva R; de Souza HS
Inflamm Bowel Dis; 2014 Mar; 20(3):444-57. PubMed ID: 24412990
[TBL] [Abstract][Full Text] [Related]
15. Profiles of Lamina Propria T Helper Cell Subsets Discriminate Between Ulcerative Colitis and Crohn's Disease.
Li J; Ueno A; Fort Gasia M; Luider J; Wang T; Hirota C; Jijon HB; Deane M; Tom M; Chan R; Barkema HW; Beck PL; Kaplan GG; Panaccione R; Qian J; Iacucci M; Gui X; Ghosh S
Inflamm Bowel Dis; 2016 Aug; 22(8):1779-92. PubMed ID: 27243594
[TBL] [Abstract][Full Text] [Related]
16. Lnc-ITSN1-2, Derived From RNA Sequencing, Correlates With Increased Disease Risk, Activity and Promotes CD4
Nie J; Zhao Q
Front Immunol; 2020; 11():852. PubMed ID: 32547537
[No Abstract] [Full Text] [Related]
17. Serum Interleukin 9 Levels Predict Disease Severity and the Clinical Efficacy of Infliximab in Patients with Crohn's Disease.
Feng T; Chen B; Li L; Huang S; Ben-Horin S; Qiu Y; Feng R; Li M; Mao R; He Y; Zeng Z; Zhang S; Chen M
Inflamm Bowel Dis; 2017 Oct; 23(10):1817-1824. PubMed ID: 28644181
[TBL] [Abstract][Full Text] [Related]
18. Infliximab preferentially induces clinical remission and mucosal healing in short course Crohn's disease with luminal lesions through balancing abnormal immune response in gut mucosa.
Yu L; Yang X; Xia L; Zhong J; Ge W; Wu J; Liu H; Liu F; Liu Z
Mediators Inflamm; 2015; 2015():793764. PubMed ID: 25873771
[TBL] [Abstract][Full Text] [Related]
19. LncRNA ANRIL/miR-125a axis exhibits potential as a biomarker for disease exacerbation, severity, and inflammation in bronchial asthma.
Ye S; Zhu S; Feng L
J Clin Lab Anal; 2020 Mar; 34(3):e23092. PubMed ID: 31821602
[TBL] [Abstract][Full Text] [Related]
20. Correlation of Dickkopf-1 with Inflammation in Crohn Disease.
Kim MJ; Choe YH
Indian Pediatr; 2019 Nov; 56(11):929-932. PubMed ID: 31729323
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
